PSIL
Exchange-traded product on NYSE (US)
- Type
- Exchange-traded product
- Share class
- —
- Status
- listed
- ISIN
- —
- Currency
- —
- Represents the company
- No
Holdings as of Nov 17, 2026
The full portfolio the fund publishes every business day on its website (advisorshares.com). Every line is listed: holdings we could identify link to their page, the rest (cash, options, swaps, private shares, securities we do not carry) are shown as the fund prints them. Short positions are negative. Change is the share count against Nov 16, 2026.
29 lines, 22 linked, weights sum to 99.98% · Actively managed (N-CEN)
| Holding | Ticker / identifier | Type | Shares | Change | Weight | Market value |
|---|---|---|---|---|---|---|
| DEFINIUM THERAPEUTICS INC | DFTX 24477V105 | Equity | 153,124 | 0 | 11.81% | $ 4.499M |
| COMPASS PATHWAYS PLC | CMPS 20451W101 | Equity | 494,395 | 0 | 10.35% | $ 3.945M |
| HELUS PHARMA INC | HELP 423492107 | Equity | 392,147 | 0 | 7.41% | $ 2.823M |
| ELI LILLY & CO | LLY 532457108 | Equity | 1,860 | 0 | 6.91% | $ 2.633M |
| NEUROCRINE BIOSCIENCES INC | NBIX 64125C109 | Equity | 14,954 | 0 | 6.51% | $ 2.481M |
| ABBVIE INC | ABBV 00287Y109 | Equity | 8,071 | 0 | 6.20% | $ 2.363M |
| SUPERNUS INC | SUPN 45579U109 | Equity | 71,341 | 0 | 5.44% | $ 2.072M |
| RELMADA THERAPEUTICS INC | RLMD 75955J402 | Equity | 663,176 | 0 | 5.24% | $ 1.996M |
| SEAPORT THERAPEUTICS INC | SPTX 81221K108 | Equity | 109,334 | 0 | 5.21% | $ 1.987M |
| JOHNSON & JOHNSON | JNJ 478160104 | Equity | 6,842 | 0 | 5.00% | $ 1.907M |
| GH RESEARCH PLC | GHRS G3855L106 | Equity | 102,038 | 0 | 4.89% | $ 1.864M |
| NRX PHARMACEUTICALS INC | NRXP 629444209 | Equity | 740,811 | 0 | 4.76% | $ 1.815M |
| ALTO NEUROSCIENCE INC | ANRO 02157Q109 | Equity | 71,847 | 0 | 4.70% | $ 1.79M |
| NEURONETICS INC | STIM 64131A105 | Equity | 1,098,644 | 0 | 3.69% | $ 1.406M |
| BRIGHT MINDS BIOSCIENCES INC | DRUG 10919W405 | Equity | 48,217 | 0 | 2.60% | $ 988.931K |
| NEUPHORIA THERAPEUTICS INC | NEUP 64136E102 | Equity | 290,653 | 0 | 1.73% | $ 659.782K |
| PSYENCE BIOMEDICAL LTD | PBM 74449F407 | Equity | 258,157 | 0 | 1.70% | $ 647.974K |
| QUANTUM BIOPHARMA-B SUB VOT | QNTM 74764Y205 | Equity | 391,932 | 0 | 1.64% | $ 623.172K |
| OPTIMI HEALTH CORP | OPTH 68405H308 | Equity | 266,914 | 0 | 1.47% | $ 560.519K |
|
BLACKROCK TREASURY TRUST INSTL 62
|
X9USDBLYT | Money market | 344,797.13 | +216,150.39 | 0.90% | $ 344.797K |
| INCANNEX HEALTHCARE INC | IXHL 45333F208 | Equity | 156,359 | 0 | 0.71% | $ 272.065K |
|
NUMINUS WELLNESS INC
|
NUMIF 67054W103 | Equity | 9,748,746 | 0 | 0.44% | $ 166.704K |
| IGC PHARMA INC | IGC 45408X308 | Equity | 872,689 | 0 | 0.43% | $ 163.978K |
| SILO PHARMA INC | SILO 82711P300 | Equity | 96,113 | 0 | 0.42% | $ 161.47K |
|
CASH
|
Cash short | -66,929.47 | −217,026.61 | -0.18% | $ -66.929K | |
|
CONTRA ATAIBECKLEY INC
|
046CVR015 | Equity | 606,427 | 0 | — | — |
|
QUANTUM BIOPHARMA LTD
|
747CNT053 | Equity | 46,617 | 0 | — | — |
|
SAGE THERAPEUTICS CVR
|
786CVR019 | Equity | 89,780 | 0 | — | — |
|
UNBUZZD WELLNESS INC
|
BMY9R83 | Equity | 10,967 | 0 | — | — |